Following the End-of-Phase 2 meeting with the FDA, the Company gained alignment on its Phase 3 program for the treatment of patients with idiopathic pulmonary fibrosis-related chronic cough On track ...
Following the End-of-Phase 2 meeting with the FDA, the Company gained alignment on its Phase 3 program for the treatment of patients with ...
Trevi Therapeutics (TRVI) advances Haduvio for IPF cough/RCC; Phase 2 IPF data strong, but funding, safety & opioid-label ...
The Company will conduct two Phase 3 clinical trials of nalbuphine ER for the treatment of patients with IPF-related chronic coughFirst pivotal ...
As GLP-1 use has expanded well beyond obesity and diabetes, clinicians are encountering a broader range of real-world symptoms — some anticipated, others less clearly defined. For primary care ...
A Virtual Physiotherapy Group Intervention for Chronic Cough (ViP-Cough) achieved 80% uptake, with patients who received this intervention showing significant reductions in cough severity, cough ...
Introduction Previous studies have pointed out that persistent cough is a common complication after pulmonary resection and its occurrence is closely related to inflammatory response. However, there ...
Archana Koirala has done research with funding from the Australian Department of Health, Disability and Ageing, and NSW health. She is the chair of the Vaccination Special Interest Group and a ...
Most cancer patients hope their tumors disappear quickly, but a UK mom is actually “waiting” for hers to grow. “I am constantly waiting for the tumors to grow big enough to get treatment that is ...
Hosted on MSN
What Is a Lung Cancer Cough?
A cough is one of the most common symptoms that sends people to the doctor. As many as 30 million medical visits are related to coughing. Most coughs are caused by upper respiratory infections like a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results